I. Duijkers

发表

Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.

J. Foidart, J. Rosing, C. Klipping, 2020, Contraception.

Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive

C. Klipping, U. Mellinger, M. Serrani, 2011, Drugs in R&D.

Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study

J. Foidart, H. C. Coelingh Bennink, C. Klipping, 2015, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Original research article Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study

J. Endrikat, C. Klipping, M. Serrani, 2013 .

Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study.

J. Endrikat, C. Klipping, M. Serrani, 2013, Contraception.

Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing

T. Frenkl, D. Heger-Mahn, C. Klipping, 2018, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function.

J. Foidart, C. Klipping, M. Jost, 2021, Contraception.

Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women

C. Klipping, I. Duijkers, 2010 .

Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women.

C. Klipping, I. Duijkers, 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

A comparative study on the effects of a contraceptive vaginal ring NuvaRing® and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function

S. Killick, T. Dieben, A. Bigrigg, 2004, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.

C. Klipping, R. Massai, T. Dieben, 2005, Human reproduction.

Pharmacokinetics of two human menopausal gonadotrophin preparations after single intravenous administration during pituitary suppression.

H. C. Coelingh Bennink, F. Rombout, H. Vemer, 1995, Human reproduction.

Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.

J. Foidart, C. Klipping, C. Maillard, 2021, Contraception.

Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females.

C. Klipping, G. Voortman, J. D. de Bie, 2002, Human reproduction.

Original research article Maintenance of ovulation inhibition with the 75-lg desogestrel-only contraceptive pill (CerazetteR) after scheduled 12-h delays in tablet intake

D. Heger-Mahn, C. Klipping, T. Dieben, 2005 .

Maintenance of ovulation inhibition with the 75-microg desogestrel-only contraceptive pill (Cerazette) after scheduled 12-h delays in tablet intake.

D. Heger-Mahn, C. Klipping, T. Dieben, 2005, Contraception.

Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle.

C. Verhoeven, C. Klipping, T. Dieben, 2004, Human reproduction.

A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24/4 regimen

D. Heger-Mahn, S. Skouby, D. Drouin, 2015, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol.

J. Foidart, C. Kluft, C. Klipping, 2017, Contraception.

Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparations.

H. C. Coelingh Bennink, C. Klipping, H. Out, 1997, Human reproduction.

Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study

C. Klipping, Michel P Fortier, J. Marr, 2012, Journal of Family Planning and Reproductive Health Care.

Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study

C. Klipping, Michel P Fortier, J. Marr, 2012, Journal of Family Planning and Reproductive Health Care.

Length of the menstrual cycle after discontinuation of oral contraceptives

C. Klipping, I. Duijkers, Lonneke Engels, 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Gonadotrophins, some basic and clinical aspects

I. Duijkers, 1995 .

Emergency contraceptive pills: medical and service delivery guidelines. 3rd ed.

Brache, J. Trussell, R. Reid, 2012 .

A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials

C. Klipping, S. Goletz, B. Dietrich, 2017, Human reproduction.

Serum levels of follicle-stimulating hormone and luteinizing hormone after subcutaneous administration of human menopausal gonadotropin during pituitary suppression.

Y. Magnusson, H. M. Hollanders, I. Duijkers, 1995, International journal of fertility and menopausal studies.

Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol

C. Klipping, P. Grob, I. Duijkers, 2010, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.

J. Endrikat, C. Klipping, W. Schmidt, 2008, Contraception.

Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.

C. Verhoeven, C. Klipping, T. Dieben, 2004, Human reproduction.

Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women.

A. Schueler, R. Hermann, K. Erb, 2001, Fertility and sterility.

Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers.

R. Hermann, C. Klipping, G. Niebch, 1998, Human reproduction.

Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.

C. Klipping, J. Marr, I. Duijkers, 2008, Contraception.

Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo

I. Klingmann, M. Wargenau, C. Klipping, 2018, Human reproduction.